- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 5/0783 - Cellules TCellules NKProgéniteurs de cellules T ou NK
Détention brevets de la classe C12N 5/0783
Brevets de cette classe: 13168
Historique des publications depuis 10 ans
|
600
|
793
|
1032
|
1187
|
1277
|
1446
|
1310
|
1350
|
1303
|
943
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1127 |
655 |
| Iovance Biotherapeutics, Inc. | 416 |
289 |
| The Regents of the University of California | 20987 |
284 |
| The Trustees of the University of Pennsylvania | 4447 |
233 |
| Board of Regents, The University of Texas System | 6206 |
164 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3031 |
160 |
| Memorial Sloan-Kettering Cancer Center | 2071 |
142 |
| Cellectis | 416 |
139 |
| Juno Therapeutics, Inc. | 505 |
119 |
| Immunitybio, Inc. | 517 |
119 |
| Baylor College of Medicine | 1022 |
118 |
| The Board of Trustees of the Leland Stanford Junior University | 6734 |
110 |
| Novartis AG | 10160 |
102 |
| Kite Pharma, Inc. | 455 |
99 |
| City of Hope | 1051 |
96 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1048 |
92 |
| Autolus Limited | 271 |
89 |
| Takeda Pharmaceutical Company Limited | 2708 |
86 |
| Kyoto University | 2957 |
81 |
| Regents of the University of Minnesota | 2819 |
80 |
| Autres propriétaires | 9911 |